Pure Biologics

Pure Biologics Acquisitions (Net)

The Acquisitions (Net) of Pure Biologics (PUR.WA) as of Oct 21, 2026 is 3.56 M PLN. In the previous year, Acquisitions (Net) was 567,000.00 PLN — a change of 527.69% (higher).

Acquisitions (Net)

3.56 MPLN

YoY

527.69%

Last updated:

Acquisitions (Net) of Pure Biologics is 2024 3.56 M PLN. Acquisitions (Net) of Pure Biologics was 2023 567,000.00 PLN. It decreases by 527.69% higher compared to the previous year.

The Pure Biologics Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2017
0.00 PLN
Jan 1, 2018
0.00 PLN
Jan 1, 2019
0.00 PLN
Jan 1, 2020
0.00 PLN
Jan 1, 2021
-27.81 M PLN
Jan 1, 2022
21.10 M PLN
Jan 1, 2023
567,000.00 PLN
Jan 1, 2024
3.56 M PLN
The Pure Biologics Acquisitions (Net) history
YEARAcquisitions (Net)YoY
3.56 MPLN+527.69%
567,000.00PLN-97.31%
21.10 MPLN-175.90%
-27.81 MPLN—
0.00PLN—
0.00PLN—
0.00PLN—
0.00PLN—
0.00PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pure Biologics Stock analysis

What does Pure Biologics do? Pure Biologics SA, headquartered in Wrocław, Poland, operates in the Health Care sector as a biotechnology company. It focuses on research and development of innovative biological medicines and medical devices for therapeutic and diagnostic applications. The company employs 53 full-time staff and was listed on the stock market on 11 December 2018. Founded in August 2010, it remains based in Wrocław, focusing on biopharmaceutical solutions. Pure Biologics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pure Biologics stock

Acquisitions (Net) of Pure Biologics is 3.56 M PLN in 2024.

Acquisitions (Net) of Pure Biologics changed from 567,000.00 PLN to 3.56 M PLN, representing a 527.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Pure Biologics since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Pure Biologics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Pure Biologics

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Pure Biologics